CNTN · Canton Strategic Holdings Inc
United States · RS rating 30 · As of 2026-11-03
| Price | 1.95 USD |
|---|---|
| 1-day change | -4.4% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 25 / 72 / 29 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 7 / 39 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +60.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +64.4% |
| Market cap (USD) | $190.9M |